Wenbin Jiang Ph.D.
Net Worth
Last updated:
What is Wenbin Jiang Ph.D. net worth?
The estimated net worth of Dr. Wenbin Jiang Ph.D. is at least $27,045,428 as of 18 Nov 2024. He owns shares worth $21,314,216 as insider, has earned $4,671,852 from insider trading and has received compensation worth at least $1,059,360 in Cytek Biosciences, Inc..
What is the salary of Wenbin Jiang Ph.D.?
Dr. Wenbin Jiang Ph.D. salary is $353,120 per year as Pres, Chief Executive Officer & Director in Cytek Biosciences, Inc..
How old is Wenbin Jiang Ph.D.?
Dr. Wenbin Jiang Ph.D. is 61 years old, born in 1964.
What stocks does Wenbin Jiang Ph.D. currently own?
As insider, Dr. Wenbin Jiang Ph.D. owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Cytek Biosciences, Inc. (CTKB) | Pres, Chief Executive Officer & Director | 5,275,796 | $4.04 | $21,314,216 |
What does Cytek Biosciences, Inc. do?
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system, which leverages full spectrum profiling technology to further broaden potential applications across cell analysis. The company also provides reagents and kits, including cFluor reagents, which are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, which are automated plate loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific region; and through distributors or sales agents in European, Latin American, the Middle Eastern, and the Asia-Pacific countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.
Wenbin Jiang Ph.D. insider trading
Cytek Biosciences, Inc.
Dr. Wenbin Jiang Ph.D. has made 23 insider trades between 2022-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 66,665 units of CTKB stock on 4 Mar 2022. As of 18 Nov 2024 he still owns at least 5,275,796 units of CTKB stock.
Cytek Biosciences key executives
Cytek Biosciences, Inc. executives and other stock owners filed with the SEC:
- Dr. Ming Yan Ph.D. (62) Chief Technology Officer & Director
- Dr. Wenbin Jiang Ph.D. (61) Pres, Chief Executive Officer & Director
- Mr. Patrik Sebastian Jeanmonod (59) Chief Financial Officer